Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blackstone Horizon is an investment business within Blackstone focused on generating absolute returns through investments in and strategic partnerships with external investment managers. It was launched as part of Blackstone Alternative Asset Management's growth strategy and has been described as using a thematic approach tied to secular growth trends. Available public information indicates that it is a financial investment platform rather than a biotechnology, pharmaceutical, or healthcare operating company. There is no evidence that Blackstone Horizon develops therapeutics, runs a clinical pipeline, or operates as a life sciences company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Blackstone Horizon.